EyubogluM. Effects of renin–angiotensin–aldosterone system blockers and renoprotective regimens on contrast-induced nephropathy. Angiology. 2015. doi: 10.1177/0003319715595331.
2.
KocasCYildizAAbaciO. Platelet-to- lymphocyte ratio predicts contrast-induced nephropathy in patients with non-ST segment elevation acute coronary syndrome. Angiology. 2015. doi: 10.1177/0003319715578057.
3.
Authors/Task Force members; WindeckerSKolhPAlfonsoF. 2014ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619.
4.
BarısNÖzpelitEDoğanNB. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients. Anadolu Kardiyol Derg. 2013;13(3):245–250.
